MANKIND PHARMA
Back to Cashflow Statement
|
MANKIND PHARMA Last 5 Year Net Cash Inflow / Outflow History
[Consolidated]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| Net Cash Inflow / Outflow | ₹-28 Cr | ₹-37 Cr | ₹76 Cr | ₹19 Cr | ₹155 Cr |
What is the latest Net Cash Inflow / Outflow ratio of MANKIND PHARMA ?
| Year | Net Cash Inflow / Outflow |
|---|---|
| Mar2026 | ₹-28 Cr |
| Mar2025 | ₹-37 Cr |
| Mar2024 | ₹76 Cr |
| Mar2023 | ₹19 Cr |
| Mar2022 | ₹155 Cr |
How is Net Cash Inflow / Outflow of MANKIND PHARMA Trending?
| Years | Net Cash Inflow / Outflow | % Change | |
|---|---|---|---|
| Mar2026 | ₹-28 Cr | Negative | |
| Mar2025 | ₹-37 Cr | Negative | |
| Mar2024 | ₹76 Cr | 290.95 | |
| Mar2023 | ₹19 Cr | -87.48 | |
| Mar2022 | ₹155 Cr | - | |
Compare Net Cash Inflow / Outflow of peers of MANKIND PHARMA
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| MANKIND PHARMA | ₹96,169.1 Cr | -2.9% | -4.2% | -6.9% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹455,634.0 Cr | -2.9% | -2.3% | 21.8% | Stock Analytics | |
| DIVIS LABORATORIES | ₹241,576.0 Cr | -1.6% | 9.8% | 51.8% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹184,478.0 Cr | -2.6% | -2.3% | 37.5% | Stock Analytics | |
| CIPLA | ₹111,888.0 Cr | -2.2% | -6.1% | -12.5% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹96,322.1 Cr | -0.9% | -1.8% | -9.8% | Stock Analytics | |
MANKIND PHARMA Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| MANKIND PHARMA | -2.9% |
-4.2% |
-6.9% |
| SENSEX | -1% |
-2.6% |
-4.1% |
You may also like the below Video Courses